KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
Saved in:
| Title: | KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis. |
|---|---|
| Authors: | Limberger T; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria.; CBmed-Center for Biomarker Research in Medicine GmbH, 8010, Graz, Austria., Schlederer M; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria., Trachtová K; Central European Institute of Technology, Masaryk University, Brno, 62500, Czech Republic.; Christian Doppler Laboratory for Applied Metabolomics, 1090, Vienna, Austria.; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090, Vienna, Austria., Garces de Los Fayos Alonso I; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria.; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria., Yang J; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria., Högler S; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria., Sternberg C; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria.; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria.; Institute of Biochemistry, Christian-Albrechts-University Kiel, 24118, Kiel, Germany., Bystry V; Central European Institute of Technology, Masaryk University, Brno, 62500, Czech Republic., Oppelt J; Central European Institute of Technology, Masaryk University, Brno, 62500, Czech Republic., Tichý B; Central European Institute of Technology, Masaryk University, Brno, 62500, Czech Republic., Schmeidl M; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria., Kodajova P; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria., Jäger A; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria., Neubauer HA; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210, Vienna, Austria., Oberhuber M; CBmed-Center for Biomarker Research in Medicine GmbH, 8010, Graz, Austria., Schmalzbauer BS; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria., Pospisilova S; Central European Institute of Technology, Masaryk University, Brno, 62500, Czech Republic., Dolznig H; Institute of Medical Genetics, Medical University of Vienna, 1090, Vienna, Austria., Wadsak W; CBmed-Center for Biomarker Research in Medicine GmbH, 8010, Graz, Austria.; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090, Vienna, Austria., Culig Z; Department of Urology, Innsbruck Medical University, 6020, Innsbruck, Austria., Turner SD; Department of Pathology, University Cambridge, Cambridge, UK.; CEITEC, Masaryk University, Brno, Czech Republic., Egger G; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria.; Ludwig Boltzmann Institute Applied Diagnostics, 1090, Vienna, Austria., Lagger S; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria., Kenner L; Division of Experimental and Translational Pathology, Department of Pathology, Medical University of Vienna, 1090, Vienna, Austria. lukas.kenner@meduniwien.ac.at.; CBmed-Center for Biomarker Research in Medicine GmbH, 8010, Graz, Austria. lukas.kenner@meduniwien.ac.at.; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090, Vienna, Austria. lukas.kenner@meduniwien.ac.at.; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria. lukas.kenner@meduniwien.ac.at. |
| Source: | Molecular cancer [Mol Cancer] 2022 Mar 30; Vol. 21 (1), pp. 89. Date of Electronic Publication: 2022 Mar 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-4598 |
|---|---|
| DOI: | 10.1186/s12943-022-01542-8 |
